Last reviewed · How we verify
NCT04114500: FET
The Association Between Serum E2 and P on the Day of FET and the Pregnancy Outcome
trial testing serum estradiol and progesterone in Frozen Embryo Transfer in 402 participants. Completed in 5 May 2019.
1 May 2019
Quick facts
| Lead sponsor | Al Baraka Fertility Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 402 |
| Start date | 3 April 2018 |
| Primary completion | 1 May 2019 |
| Estimated completion | 5 May 2019 |
| Sites | 1 location across Bahrain |
Drugs / interventions tested
- serum estradiol and progesterone
Conditions studied
- Frozen Embryo Transfer — all drugs for Frozen Embryo Transfer →
Sponsor
Al Baraka Fertility Hospital
Who can join
Adults 22 to 40, female only, with Frozen Embryo Transfer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The outcomes of frozen embryo transfer (FET) have substantially improved over the last decade, due to the improvements in the cryopreservation process, Artificial endometrial preparation is typically accomplished by the administration of estradiol (E2) supplementation and exogenous progesterone (P) in order to transform the endometrium into a secretory one, mimicking a natural cycle , The current study aims to determine the association, if any, between serum E2 and P levels, measured same day of FET, and pregnancy outcome
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04114500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Frozen Embryo Transfer
Currently open trials in the same condition.
- NCT06526520 — Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer · recruiting
- NCT06239376 — Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients · NA · recruiting
- NCT05332769 — Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM) · active not recruiting
- NCT04371783 — A Randomized Trial Comparing the Live Birth Rate of Immediate Versus Delayed FET Following a Freeze-all Strategy · NA · active not recruiting
Other Al Baraka Fertility Hospital trials
Trials by the same sponsor.
- NCT05699850 — ARTIFICIAL INTELLIGENCE IN REPRODUCTIVE MEDICINE · unknown
- NCT04512807 — AMH and Pregnancy Outcome in IVF · unknown
- NCT05198401 — The Impact of the Previous Exposure to Covid-19 Virus Infection on the Outcome of ICSI Cycles · completed
- NCT04310293 — Novel Therapy for Poor Responders Management · NA · unknown
- NCT04265495 — Dual Trigger, Urinary HCG or Recombinant HCG, Which is the Best !? · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04114500 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al Baraka Fertility Hospital
- Last refreshed: 8 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04114500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing